Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Nestle Wins Clearance in China for Acquisition of Pfizer Unit
Bloomberg
Friday, November 2, 2012 - 10:27am
tags:
China, Pfizer, M&A, Nestle, infant nutrition
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Friday, November 2, 2012 - 10:26am
tags:
patents, Amarin, AstraZeneca, Bristol-Myers Squibb, GSK
3 Critical Answers for MannKind
Motley Fool
Friday, November 2, 2012 - 10:17am
tags:
MannKind, Afrezza
Lilly to Expand Indianapolis Insulin Manufacturing
Pharma Pro
Friday, November 2, 2012 - 10:15am
tags:
Eli Lilly, drug manufacturing, diabetes, insulin
Bayer HealthCare joins with Medsintez to boost presence in Russia
The Pharma Letter
Friday, November 2, 2012 - 10:06am
tags:
Russia, Medsintez, Bayer
Boehringer, Ensemble join forces to discover macrocycle drugs
Pharmaceutical Business Review
Friday, November 2, 2012 - 10:03am
tags:
Boehringer Ingelheim, R&D, contract research, macrocycle drugs, Ensemble Therapeutics
Teva swings to loss on charges but sales growth is strong
Pharma Times, UK
Friday, November 2, 2012 - 9:59am
tags:
Teva Pharmaceuticals, earnings
Valeant Pharma Q3 Profit Declines; Tightens Q4, 2012 EPS Outlook
NASDAQ.com
Friday, November 2, 2012 - 9:57am
tags:
earnings, Valeant Pharmaceuticals
Vertex posts loss as hepatitis drug sales fall
Reuters
Friday, November 2, 2012 - 9:52am
tags:
earnings, Vertex Pharmaceuticals
Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch
Motley Fool
Thursday, November 1, 2012 - 6:09pm
tags:
Arena Pharmaceuticals, obesity, Vivus, Belviq, Qsymia
Johnson & Johnson Settles 845 Levaquin Lawsuits
Bloomberg
Thursday, November 1, 2012 - 6:07pm
tags:
JNJ, settlements, Levaquin
Endocyte Reports Third Quarter 2012 Financial Results and Business Update
Yahoo
Thursday, November 1, 2012 - 6:07pm
tags:
earnings, Endocyte
Pfizer's Future May Hinge On Tofacitinib FDA Action In November
Seeking Alpha
Thursday, November 1, 2012 - 6:06pm
tags:
FDA, Pfizer, tofacitinib, rheumatoid arthritis
The Gory Details on GlaxoSmithKline's Double Miss
Motley Fool
Thursday, November 1, 2012 - 5:19pm
tags:
GSK, earnings
Pfizer says to make "go or no go" decision by March 2013 on Remoxy
Reuters
Thursday, November 1, 2012 - 12:42pm
tags:
Remoxy, Pfizer
Sanofi draws fire over cost of MS drug Lemtrada
Reuters
Thursday, November 1, 2012 - 11:51am
tags:
MS, multiple sclerosis, Sanofi, Lemtrada
Medivation Prostate Cancer Drug Launches Hot
TheStreet.com
Thursday, November 1, 2012 - 11:50am
tags:
Medivation, prostate cancer, Astellas, Xtandi
Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover
Bloomberg
Thursday, November 1, 2012 - 11:49am
tags:
Medivir, hepatitis C, VX-135, Vertex Pharmaceuticals
The Wild October Ride Of Vivus
Seeking Alpha
Thursday, November 1, 2012 - 11:25am
tags:
Vivus, obesity, Arena Pharmaceuticals
Novartis to Construct $500M Biologics Plant in Singapore
Genetic Engineering News
Thursday, November 1, 2012 - 11:20am
tags:
Novartis, Singapore

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.